161 related articles for article (PubMed ID: 36004348)
21. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
Zhao L; Sun X; Luo Y; Wang F; Lyu Z
Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
[TBL] [Abstract][Full Text] [Related]
22. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.
Wen X; Jin Q; Cen X; Qiu M; Wu Z
World J Surg Oncol; 2022 Apr; 20(1):106. PubMed ID: 35365171
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
Wang ZH; Zhang YJ; Fu GM; Chen YB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
[No Abstract] [Full Text] [Related]
25. Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas.
Pyo JS; Sohn JH; Kang G; Kim DH; Yun J
Yonsei Med J; 2015 Mar; 56(2):355-61. PubMed ID: 25683981
[TBL] [Abstract][Full Text] [Related]
26. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract][Full Text] [Related]
27. Independent Risk Factors Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Yu X; Song X; Sun W; Zhao S; Zhao J; Wang YG
Horm Metab Res; 2017 Mar; 49(3):201-207. PubMed ID: 28351086
[TBL] [Abstract][Full Text] [Related]
28. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC).
Kim K; Zheng X; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocrine; 2020 Jul; 69(1):149-156. PubMed ID: 32146654
[TBL] [Abstract][Full Text] [Related]
29. Papillary thyroid microcarcinomas that metastasize to lymph nodes.
Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B
Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358
[TBL] [Abstract][Full Text] [Related]
30. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
[TBL] [Abstract][Full Text] [Related]
31. Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma.
Zhang C; Li BJ; Liu Z; Wang LL; Cheng W
Eur Arch Otorhinolaryngol; 2020 Apr; 277(4):1191-1198. PubMed ID: 31932880
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological characteristics of papillary thyroid microcarcinoma and risk factors for central lymph node metastasis].
Wu YL; Sun JM; Zhang JJ; Cui QX; Zheng WH; Li XR
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):426-429. PubMed ID: 28635214
[No Abstract] [Full Text] [Related]
33. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
34. A comparison of logistic regression and artificial neural networks in predicting central lymph node metastases in papillary thyroid microcarcinoma.
Ozden S; Er S; Saylam B; Yildiz BD; Senol K; Tez M
Ann Ital Chir; 2018; 89():193-198. PubMed ID: 30588918
[TBL] [Abstract][Full Text] [Related]
35. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
36. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Sun J; Jiang Q; Wang X; Liu W; Wang X
Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
[TBL] [Abstract][Full Text] [Related]
38. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
39. [Correlation analysis of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and central cervical lymph node metastasis of papillary thyroid microcarcinoma].
Song CY; Meng YL; Liu B; Yan L; Shang PZ; Jia ZF; Jiang YB; Meng FY
Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):944-948. PubMed ID: 34530577
[No Abstract] [Full Text] [Related]
40. Is lobectomy sufficient for multifocal papillary thyroid microcarcinoma?
Park KW; Han AY; Kim CM; Wang MB; Nguyen CT
Am J Otolaryngol; 2023; 44(4):103881. PubMed ID: 37031520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
